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Abstract
Gene set-based analysis of genome-wide association study (GWAS) data has recently emerged as a useful approach to
examine the joint effects of multiple risk loci in complex human diseases or phenotypes. Dental caries is a common, chronic,
and complex disease leading to a decrease in quality of life worldwide. In this study, we applied the approaches of gene set
enrichment analysis to a major dental caries GWAS dataset, which consists of 537 cases and 605 controls. Using four
complementary gene set analysis methods, we analyzed 1331 Gene Ontology (GO) terms collected from the Molecular
Signatures Database (MSigDB). Setting false discovery rate (FDR) threshold as 0.05, we identified 13 significantly associated
GO terms. Additionally, 17 terms were further included as marginally associated because they were top ranked by each
method, although their FDR is higher than 0.05. In total, we identified 30 promising GO terms, including ‘Sphingoid
metabolic process,’ ‘Ubiquitin protein ligase activity,’ ‘Regulation of cytokine secretion,’ and ‘Ceramide metabolic process.’
These GO terms encompass broad functions that potentially interact and contribute to the oral immune response related to
caries development, which have not been reported in the standard single marker based analysis. Collectively, our gene set
enrichment analysis provided complementary insights into the molecular mechanisms and polygenic interactions in dental
caries, revealing promising association signals that could not be detected through single marker analysis of GWAS data.
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Introduction
Dental caries (also known as tooth decay or a cavity) is simply
defined as a procedure that causes destruction and demineraliza-
tion of hard tooth tissues such as enamel, dentin, and cementum. It
is a highly pervasive chronic disease whose etiology is complex and
multifactorial, with contributions from numerous factors, includ-
ing microbial flora, salivary flow and composition, and fluoride
exposure, among others. There has been increasing evidence of
genetic components contributing to caries susceptibility
[1,2,3,4,5]. Benefiting from high-throughput genotyping technol-
ogies (up to a few million single nucleotide polymorphism (SNP)
biomarkers on a single chip), genome-wide association studies
(GWAS) have recently been employed to search for genetic
susceptibility related to dental caries [6,7,8], among hundreds of
other complex diseases and phenotypes [9]. These dental caries
GWA studies identified several loci and genes, such as ACTN2,
LYZL2, and AJAP1 [7,8]. In these GWA studies, the statistical
analyses of association signals are typically conducted for single
markers, limiting the power to identify potential truly associated
genes that may have been missed due to the multiple test
adjustment necessary to control the false discovery rate (FDR).
Recently, interrogating the joint effects of multiple risk loci or
genes through the gene set-based analysis of GWAS data has
become one popular complementary approach to single marker
association tests [10]. Gene set analysis of GWAS data has been
successfully applied to many diseases or traits (see recent reviews
[11,12]), including schizophrenia [13], major depressive disorder
[14], type II diabetes [15,16,17], Crohn’s disease [18], and several
types of cancer [19,20,21,22]. However, to our knowledge, no
such studies have been reported for gene set analysis of association
data for human caries to date. In this work, we performed a
comprehensive gene set analysis of GWAS data for dental caries,
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aiming to broaden our understanding of the role of interactions
between genes for this worldwide disease.
Over the past several years, many gene set analysis methods
have been proposed, which were extensively summarized in a
recent review [12]. These methods address two different null
hypotheses on their tests of disease associations: 1) competitive null
hypothesis (Q1), which tests whether the genes within a gene set
show the same association magnitude compared to the genes
outside the gene set; and 2) self-contained null hypothesis (Q2),
which tests whether the genes within a gene set are associated with
the disease phenotype. When the real causal genes are included in
only a few gene sets, the two tests may have similar results.
Nevertheless, the competitive tests may be less powerful when the
causal genes are shared by multiple gene sets. Apart from the
difference in the null hypotheses tested, each method has its own
strengths and limitations, and no single proposed strategy
outperforms all the others [12].
In this study, we employed four representative methods to
conduct gene set enrichment analyses for dental caries, among
which two perform competitive tests (Association List Go
AnnoTatOR (ALIGATOR) [23] and GenGen [24]) and the
other two perform self-contained tests (SNP ratio test (SRT) [25]
and the mixed model [10]). The GWAS data was collected from a
recent dental caries association study [7], and the Gene Ontology
(GO) annotation database [26] was the source for candidate gene
sets. Our study integrated the results from different approaches
and reported 13 significantly associated and 17 marginally
associated GO terms. To our knowledge, this is the first
comprehensive gene set analysis for dental caries, or generally
for dental health, to date. Our findings provide biological insights
into the potential molecular mechanisms underlying dental caries,
which helps to improve our understanding of dental caries beyond
the single marker level.
Materials and Methods
Datasets
We retrieved the dental caries GWAS data [7] from dbGaP
(http://www.ncbi.nlm.nih.gov/gap) through approved access
(dbGaP accession number: phs000095.v1.p1). A total of 4,020
individuals in this dataset have both genotype and phenotype data.
We focused on the phenotype of ‘total primary tooth caries.’ In
this dataset, the total primary tooth caries with white spots is
described by the continuous variable ‘Prim_d1ft’ and the
dichotomized variable ‘CAT1_PRIM_D1FT.’ By definition,
individuals with disease are those with Prim_d1ft $ 1 (CAT1_
PRIM_D1FT = 1) and controls are those with Prim_d1ft = 0
(CAT1_PRIM_D1FT = 0). Subjects who were between 3 and 12
years old at the time of dental exam were included. A total of 537
cases and 605 controls, among which there are 588 males and 554
females, formed our working dataset. The samples were genotyped
on the Illumina platform Human610_Quadv1_B (Illumina, Inc.).
Quality checks conducted in the original study as provided by
dbGaP resulted in 589,735 SNPs for the following analyses.
Gene set annotation
The Molecular Signatures Database (MSigDB) [27] collects
annotated gene sets from multiple sources. We downloaded the
GO annotation [26] from MSigDB (version 3.0, C5) for gene set
enrichment analysis. To avoid biological functions that are too
narrowly or too broadly defined, only gene sets containing $ 5
and # 250 genes were included in the following analyses. As a
result, 1,331 GO terms passed the criteria, and the average
number of genes per term was 44.
Statistical analysis
Logistic regression was performed for association test of each of
the 589,735 SNPs with CAT1_PRIM_D1FT using the GWAS
analysis tool PLINK [28]. The variable ‘‘age at time of dental
exam’’ was taken as a covariate in the regression. The overall
genomic inflation factor was 1.031. We denoted the test statistic of
each SNP as ti (i=1,2,…,L, where L is total number of SNPs) and
the p-value as pi (a higher ti indicates a lower pi). A SNP was
mapped to a gene if it is located in the gene region or within 20 kb
upstream or downstream of the gene. We applied this criterion
based on the previous studies [23,29,30]. The SNP-gene mapping
resulted in 20,756 protein coding genes based on the human
reference assembly hg18.
Gene set enrichment studies for GWAS data have been
proposed for several years. However, no single strategy outper-
forms all the others to date. To alleviate the potential biases in
different statistical algorithms, we chose four representative
methods to perform the gene set enrichment analysis in this
study. These methods are GenGen [24], ALIGATOR [23], SRT
[25], and the mixed model [10]. The first two methods are used to
test competitive null hypothesis (Q1), while the others are used to
test self-contained null hypothesis (Q2) [12]. We briefly describe
the methods below. More details can be found in the original
publications.
GenGen [24] is adapted from the Gene Set Enrichment
Analysis (GSEA) method [27] that was originally designed to
analyze gene expression data. The first step of this approach is to
assign each gene a significance value cj (j=1,2,…,N, where N is
the total number of genes) with the most significant ti that can be
mapped to this gene. Next, all the genes are ranked in descending
order of cj , denoted by c(1),:::,c(N). Third, for a given gene set S
consisting of Ns genes, an enrichment score (ES) is computed using
a weighted Kolmogorov-Smirnov-like running-sum statistic as
follows:
ES(S)~ max
1ƒjƒN
X
Gj [S,jƒj
jcj j
Ws
{
8<
:
X
Gj =[S,jƒj
1
N{Ns
9=
;,
where Ws~
X
Gj [S
jcj j. Finally the significance of ES(S) is
evaluated using a permutation test by shuffling the labels of cases
and controls so that the linkage disequilibrium (LD) structures
among SNPs are conserved.
The algorithm ALIGATOR [23] executes a SNP-based
resampling procedure, which can effectively reduce the potential
biases from gene size, SNP density, and LD structure. ALIGA-
TOR defines a set of significantly associated SNPs through a
predefined cutoff (e.g., p-value = 0.05). It maps these significant
SNPs to genes, which are in turn denoted as significant genes, and
counts the number of significant genes for each gene set. Then, the
algorithm performs a SNP-based resampling, during which SNPs
are selected and mapped to genes until the number of significant
genes generated by the resampling process is the same as in the
original case. Resample genes are mapped to gene sets in the same
way as in actual cases, and the numbers of significant genes per
gene set are recorded. In our analysis, we performed resampling
10,000 times. Finally, an empirical p-value is computed for each
gene set by summing the number of resampling datasets that have
a higher number of significant genes than the real case.
The SNP ratio test [25] similarly defines a set of SNPs that are
significantly associated with the disease through a predefined p-
value threshold pt. For a gene set S, the proportion of significant
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SNPs is first computed as Rs~
XM
i~1
I(pivpt)=M, where M is
the total number of SNPs mapped to all the genes in S. Then, the
p-value of Rs is estimated using a permutation by shuffling the
case/control status among samples.
The mixed model [10] employs a hierarchical generalized linear
model for gene set analysis. For each gene set, the mixed model
includes the chi-square statistic (transformed from p-value) for
each SNP as the outcome variable, random gene effects, and an
intercept corresponding to the overall association with disease for
all SNPs in the gene set. The statistical significance of the gene set
is determined based on p-value for the intercept.
Both GenGen and SRT require permutation procedure by
shuffling the case/control labels to determine the significance level.
We generated permutation data with the same parameters and
covariates 1,000 times for the use of these two algorithms. To
correct multiple comparisons, the Benjamini-Hochberg method
[31] was used to control the FDR.
Results
We performed gene set enrichment analyses of dental caries
GWAS data using four statistical methods (GenGen, ALIGA-
TOR, SRT, and the mixed model) and GO annotation terms as
the gene set pool. Setting FDR , 0.05 as the criterion to
determine the statistical significance, the mixed model identified
the largest number of GO terms that are statistically associated
with dental caries, i.e., a total of 9 GO terms. The GenGen
method claimed 4 significant GO terms, whereas no significant
results could be found by either ALIGATOR or SRT (Tables 1
and 2). Interestingly, the GO terms identified by GenGen are all
related to secretion or regulation of secretion: ‘Protein secretion,’
‘Cytokine secretion,’ ‘Regulation of protein secretion,’ and
‘Regulation of cytokine secretion.’ The mixed model identified
several GO terms that are related to neural development
(‘Regulation of axonogenesis,’ ‘Regulation of neurogenesis,’
‘Axonogenesis,’ and ‘Central nervous system development’) and
three GO terms that are related to ligase activities (‘Ligase activity
forming carbon nitrogen bonds,’ ‘Ubiquitin protein ligase activity,’
and ‘Small conjugating protein ligase activity’).
We further examined the genes that contributed to the
association of these GO terms with dental caries. Genes that
contained at least one SNP with its p-value , 0.05 calculated from
the GWAS dataset were defined as ‘‘contributing genes.’’ Table 1
shows the contributing genes for the 13 associated GO terms.
Some gene sets showing similar biological functions share many
contributing genes. For example, ‘Regulation of axonogenesis’ and
‘Regulation of neurogenesis’ shared seven genes, including some
interesting genes such as ROBO2 and SLIT2 (see Discussion
section). Notably, the gene set ‘Cell matrix junction’ that was
identified by the mixed model contains gene ACTN2, which was
reported in the original GWAS dataset with suggestive evidence
for association, but failed to meet the genome-wide significance (p-
value , 1027) [7]. Our finding confirmed this result based on
single SNP analysis of the original GWAS data at the gene set
level. To further examine whether the association of this gene set
with dental caries is driven by gene ACTN2, we excluded this gene
and performed the same gene set analysis using the mixed model
approach. Interestingly, the gene set ‘Cell matrix junction’
remained significant (FDR = 0.007) even without the gene
ACTN2, indicating that there are additional informative genes in
this gene set that contributed to the association.
Although ALIGATOR and SRT reported no significant GO
terms under the criterion FDR , 0.05, several gene sets had
reasonably low p-values before multiple testing correction and
underwent further investigation. The high FDR values are likely
due to the inherent characteristics of the algorithms used for these
approaches, which is a phenomenon noticed in previous studies
[29]. To better explore the results of ALIGATOR and SRT, we
adopted the strategy proposed in [29]. Specifically, among the four
methods we applied, the largest number of gene sets at FDR ,
0.05 was 9, as reported by the mixed model approach. Therefore,
we accordingly selected the top 9 gene sets ranked by their raw p-
values and denoted them as candidate gene sets for each of the
corresponding approaches (Table 2). Note that all the gene sets
selected in this way have nominally significant p-values (within a
range of 0 2 0.017). Among them, one gene set was identified by
three methods, and four other gene sets were identified by two
methods. Interestingly, ALIGATOR reported all five of the GO
terms that can be identified by at least two strategies. Of especial
note, the gene set ‘Sphingoid metabolic process’ was ranked as the
most significant by the results from both ALIGATOR and SRT.
The four other gene sets included ‘Ligase activity forming carbon
nitrogen bonds,’ which was discovered by ALIGATOR, GenGen,
and the mixed model, ‘Ubiquitin protein ligase activity’ by
ALIGATOR and the mixed model, ‘Regulation of cytokine
secretion’ by ALIGATOR and GenGen, and ‘Ceramide meta-
bolic process’ by ALIGATOR and SRT. Note that GenGen and
ALIGATOR are methods to investigate the competitive null
hypothesis (Q1), and SRT and the mixed model are used for the
self-contained null hypothesis (Q2). We saw from Table 2 that four
gene sets were identified for both Q1 and Q2: ‘Sphingoid
metabolic process,’ ‘Ligase activity forming carbon nitrogen
bonds,’ ‘Ubiquitin protein ligase activity,’ and ‘Ceramide meta-
bolic process.’ In total, we listed 30 top GO terms in Table 2.
In addition, we examined the set sizes (i.e., the number of genes)
of the gene sets identified by each method. The sizes of the gene
sets identified by the mixed model were greater than that of other
methods. The median value of set sizes for the top 9 GO terms
identified by the mixed model was 43, whereas the corresponding
numbers were 18 for GenGen, 24 for ALIGATOR, and 23 for
SRT, respectively. Meanwhile, the SNP density (represented by
median number of SNPs per gene) in the GO terms discovered by
four approaches are similar, i.e., 13, 12, 13, and 12 for the mixed
model, GenGen, ALIGATOR, and SRT, respectively.
We further examined the association signals of the genes that
resided in the 30 top GO terms reported by four different
methods. A gene was considered nominally significant if it
contained at least one SNP with its p-value , 0.05. Using this
criterion, we found 383 nominally significant genes, among which
36 were involved in at least 4 GO terms (Table 3). The complete
description of all the 383 significant genes was shown in the
supplementary materials (Table S1). We used the Ingenuity
Pathway Analysis (IPA, http://www.ingenuity.com, accessed in
January, 2013) software to further investigate the phenotype
annotations of these nominally significant genes. We searched the
IPA using ‘‘dental’’ as the keyword in the category of ‘Functions
and Diseases’ and obtained 122 related function annotation items.
Eight of the 383 nominally significant genes were found in the
dental related Ingenuity annotations: PBX3, PBX1, BCOR, GLI2,
SHH, DIAPH1, SOX3, and RECQL4. They are mainly related to
the Ingenuity functions ‘dental development’ and ‘dental disorder’
(Table S1).Of special note, association between BCOR and pit-
and-fissure surface caries has been found in a recently published
GWAS in the permanent dentition [6]. However, it failed to be
detected in primary caries through the genome-wide, single-
marker analysis approach [7].
Gene Set Enrichment Analyses of Dental Caries
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Discussion
With many GWAS datasets having been released, gene set
enrichment analysis was proposed as an important and comple-
mentary approach to the traditional single marker analysis of
GWAS data. Compared to single marker analysis, gene set
analysis focuses more on biological functions of gene products as
well as their regulation in the cellular systems. Thus, this strategy
has advantages in revealing potential molecular mechanisms
underlying diseases or traits. In addition, both real and simulation
studies indicated that gene set enrichment analysis could increase
the power of detecting association signals [10,19]. In this study, we
conducted a comprehensive gene set analysis for dental caries
GWAS data [7]. Applying four methods (GenGen, ALIGATOR,
SRT, and the mixed model), we identified 30 GO terms that were
significantly or marginally associated with dental caries (Table 2).
Among them, five gene sets were identified by at least two
enrichment methods (i.e. ‘Ligase activity forming carbon nitrogen
bonds,’ ‘Regulation of cytokine secretion,’ ‘Ceramide metabolic
process,’ ‘Sphingoid metabolic process,’ and ‘Ubiquitin protein
ligase activity’). While definitive roles for the gene sets cannot be
identified as sufficient to cause cariogenesis, the five GO terms are
plausible factors for disease. These terms encompass broad
functions that potentially interact and contribute to the oral
immune response to caries-related organisms. The oral environ-
ment contains bacteria that may lead to a host inflammatory
response eliciting cytokines [32,33,34]. This inflammatory re-
sponse involves the sphingolipds, of which sphingoids and
ceramides are constituent components released during the
response [35,36]. Anaerobic organisms present in the oral cavity
thrive under hypoxic conditions, which have been observed to
stimulate cytokine production regulated by ubiquitin protein
ligases [33,37,38,39]. While no direct action from carbon nitrogen
bond ligases is identified within the immune response pathways, it
is possible that they function in a parallel maintenance mechanism
for the immune-related pathways.
Table 1. Gene Ontology (GO) terms significantly associated with dental caries (FDR , 0.05).
GO term
# genes
in term
Ratio of
significant
SNPsa Contributing genesb
Method
(FDRc)
Protein secretion 32 39/739 ARFGAP3, LTBP2, CADM1, ABCA1, APOA1, ANG, INS, CRTAM, CARD8, CIDEA, ARFIP1,
NLRP3, FOXP3, BACE2, NLRP12, GLMN, ARL4D
GenGen
(,0.001)
Cytokine secretion 18 23/468 CARD8, CRTAM, CADM1, CIDEA, ABCA1, NLRP3, FOXP3, APOA1, INS, NLRP12, GLMN GenGen
(,0.001)
Regulation of protein
secretion
22 27/391 CARD8, CRTAM, CADM1, CIDEA, ARFIP1, NLRP3, FOXP3, APOA1, INS, ANG, NLRP12,
GLMN
GenGen
(,0.001)
Regulation of cytokine
secretion
16 21/276 CARD8, CRTAM, CADM1, CIDEA, NLRP3, FOXP3, APOA1, INS, NLRP12, GLMN GenGen
(,0.001)
Regulation of axonogenesis 10 45/575 RTN4, KLK8, ROBO1, MAPT, ROBO2, LRRC4C, SLIT2 Mixed model
(,0.001)
Regulation of neurogenesis 14 45/651 RTN4, KLK8, ROBO1, MAPT, ROBO2, LRRC4C, SLIT2 Mixed model
(0.003)
Central nervous system
development
122 372/6137 GRIK1, SNCA, SHH, WNT1, PDGFC, ROBO2, UNC5C, EIF2B2, EIF2B3, SH3GL3, MDGA1,
MDGA2, SH3GL2, ADORA2A, SOX3, DSCAML1, TAGLN3, SOX8, ATN1, B3GNT5, LHX6,
IL1RAPL2, NKX2-2, DMBX1, JRKL, CELSR1, NEUROG3, SERPINI1, NCKAP1, S100B, MYO16,
POU6F1, POU6F2, GLI2, PTEN, MBP, NDUFS4, PCP4, CNTN6, ALK, SLIT1, SLIT3, BPTF,
CNTN4, SHROOM2, SHROOM4, UBE3A, ZBTB16, ALDH3A2, NPAS2, NPTX1, DNER, DCLK1,
JARID2, PTPRZ1, MAL, AFF2, RCAN1, PARK2, EIF2B1, RPS6KA6, ACCN1, MAP1S, DRP2,
PHGDH, PBX1, PBX3
Mixed model
(0.005)
Ligase activity forming
carbon nitrogen bonds
68 111/1485 RNF217, HLCS, MYLIP, WWP2, FBXO22, UBR3, UBE2H, BRAP, UHRF2, UBR5, UBE2M,
DDB2, FBXL6, ZER1, ADSS, SYVN1, GCLC, ANAPC10, CTPS2, ASNS, PFAS, UBE2D2,
FBXO3, FBXO7, CBL, MALT1, PARK2, UBE2L3, CPS1, SMURF1, PAICS, UBE2E1
Mixed model
(0.009)
Ubiquitin protein ligase
activity
49 84/1175 RNF217, MYLIP, WWP2, FBXO22, UBR3, UBE2H, BRAP, UHRF2, UBR5, UBE2M, DDB2,
FBXL6, ZER1, ANAPC10, UBE2D2, FBXO3, FBXO7, CBL, MALT1, PARK2, UBE2L3,
SMURF1, UBE2E1
Mixed model
(0.013)
Small conjugating protein
ligase activity
51 84/1209 RNF217, MYLIP, WWP2, FBXO22, UBR3, UBE2H, BRAP, UHRF2, UBR5, UBE2M, DDB2,
FBXL6, ZER1, ANAPC10, UBE2D2, FBXO3, FBXO7, CBL, MALT1, PARK2, UBE2L3,
SMURF1, UBE2E1
Mixed model
(0.014)
Glycoprotein catabolic
process
12 21/267 ADAMTS9, PSEN2, ABCG1 Mixed model
(0.031)
Axonogenesis 43 171/2782 RTN4, NRP2, PARD3, NRP1, RTN4RL1, LRRC4C, GLI2, PAX2, SHH, ROBO1, MAPT, ROBO2,
UNC5C, SPON2, PARD6B, KLK8, NRXN3, NTNG1, NTNG2, NRXN1, SLIT1, SLIT2, S100B,
CYFIP1, OPHN1, CNTN4, FEZ1
Mixed model
(0.035)
Cell matrix junction 16 45/447 PTPRC, LIMA1, BCAR1, ACTN1, ACTN2, VCL, SORBS1, LAYN, DST Mixed model
(0.035)
aThe numerator is the number of SNPs with a p-value , 0.05 from the dental caries GWAS, and the denominator is the total number of SNPs mapped to the genes in
each GO term.
bGenes containing at least one SNP with a p-value , 0.05 from the dental caries GWAS are regarded as contributing genes.
cFDR adjustment is based on Benjamini-Hochberg method [31].
doi:10.1371/journal.pone.0072653.t001
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We further investigated the 36 identified genes associated with
the 30 top GO terms (Table 3) for their potential overlap with
caries development. For each gene, the GeneCards (http://www.
genecards.org/) entry (summaries and function) and OMIM
(http://omim.org/) entry were queried to summarize gene
functions. GeneCards aliases were also searched for in OMIM.
A query for gene name and each alias cross-listed with ‘‘caries’’,
‘‘tooth’’, and ‘‘dentin’’ was conducted in PubMed to further assess
known genetic roles related to dental caries.
Based on our gene-based literature search, five genes from
either ligase activity (gene: WWP2, RNF217), neuronal develop-
ment (gene: ROBO2, SLIT2), or cytokine/protein secretion (gene:
INS) gene sets listed in Table 2 might be potentially associated with
dental traits. Only the cytokine/protein secretion term was
identified by more than 2 gene set enrichment methods. WWP2
is a member of ligase activity pathways and functions as a ligase for
and mediates degradation of PTEN, whose gene is expressed in
mouse oral development [40,41]. RNF217 is located at 6q22.31, a
genomic region reported to be associated with oral cleft [42].
ROBO2 is a receptor for SLIT2 and possibly SLIT1. SLIT1 and
SLIT2 appear to work cooperatively to establish anatomical
midlines during neuronal development and establishment of
Table 3. Enriched genes in the 30 top Gene Ontology (GO) terms.
Genea # terms involved Ratio of significant SNPsb Most significant SNP p-valuec
PARK2 6 28/512 rs574165 0.001
UBR3 6 2/36 rs16857407 0.020
ANAPC10 5 1/8 rs1455137 0.035
BRAP 5 1/11 rs10744774 0.019
CADM1 5 2/72 rs6589485 0.006
CARD8 5 5/23 rs10416565 0.008
CBL 5 2/13 rs2249466 0.027
CRTAM 5 2/22 rs3107606 0.009
DDB2 5 2/7 rs3781619 0.013
FBXL6 5 3/8 rs3817681 0.016
FBXO22 5 3/5 rs335675 0.011
FBXO3 5 1/28 rs831627 0.004
FBXO7 5 8/29 rs738263 0.007
GLMN 5 1/3 rs3103174 0.017
INS 5 3/9 rs11042978 0.002
MALT1 5 3/22 rs9783885 0.021
MYLIP 5 6/18 rs11969250 0.004
NLRP3 5 3/40 rs9988572 0.001
RNF217 5 2/42 rs552705 0.029
SMURF1 5 2/16 rs12672417 0.020
UBE2D2 5 2/7 rs769052 0.033
UBE2E1 5 4/20 rs12629302 0.008
UBE2H 5 1/24 rs10246707 0.024
UBE2L3 5 1/10 rs13054355 0.006
UBE2M 5 3/8 rs7249714 0.006
UBR5 5 4/27 rs10102559 0.003
UHRF2 5 1/24 rs1547258 0.030
WWP2 5 3/28 rs7200005 0.011
ZER1 5 1/4 rs10988111 0.017
APOA1 4 1/6 rs10047459 0.015
CCKBR 4 2/19 rs2880829 0.004
CIDEA 4 1/16 rs8084404 0.040
FOXP3 4 1/7 rs5906761 0.016
NLRP12 4 2/19 rs7259148 0.005
ROBO2 4 15/171 rs9836971 0.005
SLIT2 4 6/106 rs12503652 0.003
aGenes that have at least one SNP with a p-value , 0.05 and are involved in at least 4 gene sets were listed.
bThe numerator is the number of SNPs with a p-value , 0.05 in a gene and the denominator is the total number of SNPs mapped to the gene.
cThe p-value of the most significant SNP in the gene.
doi:10.1371/journal.pone.0072653.t003
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olfactory organization [43]. Gene SLIT1 is also expressed in the
primary and secondary enamel knots during molar tooth cusp
formation [44]. INS may impact caries through insulin sensitivity
[45] or more controversially through the activation of dentin-
related genes [46,47]. Insulin receptor binding sites are present on
rat incisors [48]. None of these relationships are ‘‘smoking guns’’
for caries development, but the gene sets and the subset of tooth-
related genes raise interesting possible mechanisms for caries.
These contributing genes encompass multiple functions or
biological processes related to tooth development or dental caries,
suggesting that our gene set enrichment analysis was effective and
the findings were insightful to the understanding of molecular
mechanisms of disease at the system level.
Although the genetic research has been applied to dental caries
for a long time (see a recent review [49]), interpretation of the
results remains challenging. In our gene set enrichment analysis,
few GO terms or genes we identified exhibit explicit roles for caries
development. One possible reason is the complex characteristics of
dental caries. While many caries risk factors have been reported,
few of them have been rigorously replicated or confirmed [8].
Thus, the predefined gene sets may be too general to play
definitive functions in cariogenesis.
In this study, four popular gene set analysis methods, i.e.,
GenGen, ALIGATOR, SRT, and the mixed model, were applied
to a real GWAS dataset. Although our primary interest is to unveil
the genetic components of dental caries, these results also provided
a comprehensive benchmark resource to compare these methods.
We only observed limited consistency among the outputs of
different algorithms. The inconsistency is not unexpected, mainly
because different methods employ different intrinsic strategies and
may test different null hypotheses (i.e., competitive vs. self-
contained null hypothesis). In addition, different ways to
preprocess GWAS data might influence the enrichment results.
For example, one important step in performing gene set analysis of
GWAS data is to map SNPs to genes and compute a gene-based
statistical value. Typically, only a subset of SNPs within a gene
plays roles in the disease, yet taking all the SNPs into account will
likely reduce the test power. However, in practical applications, it
is difficult to find the most relevant SNPs for gene set analysis.
Many approaches, like GenGen, denote the most significant SNP
as gene’s representative, which may exclude important additional
SNPs if a gene has more than one association signal. Using
ALIGATOR, all SNPs mapped to a gene are consulted, and a
gene is defined as significant if it harbors at least one nominally
significant SNP, requiring a predefined threshold that may be
chosen arbitrarily. Therefore, the analysis results from ALIGA-
TOR could be sensitive to the choice of threshold in different data
sets [23]. Similarly, in the SRT method, all SNPs mapped to a
gene are considered, and this approach also requires a preselected
threshold to define the associated SNPs. One advantage in SRT is
its incorporated permutation test by randomly swapping case/
control labels among samples to reduce the sensitivity driven by
the choice of threshold. In contrast, the mixed model approach
accounts for the p-values of all the SNPs mapped to a gene without
requiring predefined thresholds. Thus, this method avoids
potential arbitrary definitions and quantitatively leverages the
information of all SNPs.
One limitation in this study is the FDR values attained using the
four methods are quite different from each other. The top 9 GO
terms identified by ALIGATOR had an FDR value of 1. The
situation is better in SRT, but the top GO terms also hardly reach
a noteworthy FDR significance level. The high FDR could be the
result of several factors. One is the inherent drawbacks of the tools
used. For example, two GO terms, ‘Ligase activity forming carbon
nitrogen bonds’ and ‘Ubiquitin protein ligase activity,’ were
ranked as the fourth and the fifth most significant gene sets,
respectively, in both results by ALIGATOR and the mixed model.
However, their FDR values differed substantially in the two
results. Another possible reason for this high FDR might be
attributed to the incomplete information in the current annotation
databases, especially for some phenotypes without much molecular
biology knowledge. In contrast to most common diseases such as
cancer, the functional annotation for dental caries has been very
limited so far. In fact, we also performed a gene set enrichment
analysis using the canonical pathways from KEGG [50], a widely
used pathway database. There were only a small number of
KEGG pathways eligible for our analysis (181 pathways with $ 5
and # 250 genes), and none were significant KEGG pathways at
FDR , 0.05. The failed detection of promising pathways for
dental caries reflected that most, if not all, genes in the current
version of the KEGG database are not thoroughly annotated.
Another limitation in pathway annotations is that we used an old
version of the GO term set (MSigDB, version 3.0, C5). New
versions of GO data were released during our data analysis, which
now included more than 10,000 GO terms (06/26/2013 release).
However, major efforts are needed to process the redundancy of
genes in GO terms, as processed in version 3.0, C5, to avoid an
over-adjustment through multiple testing correction. This work, as
well as more robust pathway enrichment analysis in future, may
help better define dental caries pathways.
In summary, we applied four representative gene set enrichment
analysis methods to currently available dental caries GWAS data.
Our work, to date, is the first gene set enrichment study for this
worldwide disease. We reported 13 significantly associated and 17
marginally associated GO terms as likely involved in dental caries
via their gene functions. The findings provided insights and
interpretations into the underlying biological process for dental
caries. Our study mainly focused on genetic signals in GWAS
data. In future work, an integration of other genetic and genomic
information (such as gene expression, linkage scan and protein-
protein interaction network [51,52], evidence from multiple
species [53], and multi-dimensional functional module analysis
[54]) may open new avenues to understand the etiology of dental
caries.
Supporting Information
Table S1 List of genes that are nominally significant
with dental caries in the 30 top GO terms. This table
includes 383 nominally significant genes that appeared in the top
30 GO terms shown in Table 2. Genes that have at least one SNP
with a p-value , 0.05 are regarded as nominally significant genes
(without multiple testing correction).
(XLSX)
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